Nabriva Therapeutics AG Price on December 11, 2024
NBRVDelisted Stock | USD 1.62 0.01 0.61% |
If you're considering investing in Nabriva Stock, it is important to understand the factors that can impact its price. As of today, the current price of Nabriva Therapeutics stands at 1.62, as last reported on the 11th of December 2024, with the highest price reaching 1.63 and the lowest price hitting 1.62 during the day. We have found nine technical indicators for Nabriva Therapeutics, which you can use to evaluate the volatility of the firm. Please verify Nabriva Therapeutics' Accumulation Distribution of 0.0061, rate of daily change of 0.99, and Day Typical Price of 1.62 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
Nabriva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Nabriva |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
NBRV |
Based on monthly moving average Nabriva Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nabriva Therapeutics by adding Nabriva Therapeutics to a well-diversified portfolio.
Related Headline
Evoke Pharma Headline on 11th of December 2024
Insider Trading by MacroaxisInsider Filed transaction by Evoke Pharma 10 Percent Owner. Insider Public Trading |
Nabriva Therapeutics Valuation on December 11, 2024
It is possible to determine the worth of Nabriva Therapeutics on a given historical date. On December 11, 2024 Nabriva was worth 1.63 at the beginning of the trading date compared to the closed value of 1.62. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Nabriva Therapeutics stock. Still, in general, we apply an absolute valuation method to find Nabriva Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nabriva Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Nabriva Therapeutics' related companies.
Open | High | Low | Close | Volume | |
12/11/2024 | 1.63 | 1.63 | 1.62 | 1.62 | 0.00 |
Backtest Nabriva Therapeutics | | | Nabriva Therapeutics History | | | Nabriva Therapeutics Valuation |
Nabriva Therapeutics Trading Date Momentum on December 11, 2024
Nabriva Therapeutics Fundamentals Correlations and Trends
By evaluating Nabriva Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Nabriva Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Nabriva financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Nabriva Therapeutics Stock history
Nabriva Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Nabriva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nabriva Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nabriva Therapeutics stock prices may prove useful in developing a viable investing in Nabriva Therapeutics
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. Nabriva Therapeutics plc was incorporated in 2005 and is headquartered in Dublin, Ireland. Nabriva Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 73 people.
Nabriva Therapeutics Stock Technical Analysis
Nabriva Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Nabriva Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Nabriva Therapeutics AG cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Nabriva Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Nabriva Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nabriva Therapeutics shares will generate the highest return on investment. By undertsting and applying Nabriva Therapeutics stock market strength indicators, traders can identify Nabriva Therapeutics AG entry and exit signals to maximize returns
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Nabriva Stock
If you are still planning to invest in Nabriva Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nabriva Therapeutics' history and understand the potential risks before investing.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |